Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
212.10
-0.70 (-0.33%)
At close: Apr 13, 2026
-3.15% (1Y)
| Market Cap | 188.02B -1.9% |
| Revenue (ttm) | 81.95B +13.4% |
| Net Income | 25.95B +16.0% |
| EPS | 29.27 +16.0% |
| Shares Out | 886.45M |
| PE Ratio | 7.25 |
| Forward PE | 6.58 |
| Dividend | 12.00 (5.66%) |
| Ex-Dividend Date | Nov 17, 2025 |
| Volume | 229,857 |
| Average Volume | 265,713 |
| Open | 213.50 |
| Previous Close | 212.80 |
| Day's Range | 212.00 - 214.20 |
| 52-Week Range | 198.00 - 236.00 |
| Beta | 0.11 |
| RSI | 44.99 |
| Earnings Date | Apr 29, 2026 |